Notice Number: NOT-DK-06-020

Key Dates
Release Date: November 8, 2006

Issued by
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (http://www.niddk.nih.gov)

The National Institute of Diabetes and Digestive Diseases (NIDDK) announces the termination of the following program announcements:

PA-06-142 - Non-Invasive Methods for Diagnosis and Progression of Diabetes, Kidney,
PA-06-144 - Long-Term Weight Maintenance: Basic and Clinical Studies (R21)
PA-06-146 - Development of Disease Biomarkers (R21)
PA-06-148 - Pilot and Feasibility Program Related to the Kidney (R21)
PA-06-149- Innovative and Exploratory Research in Digestive Diseases and Nutrition (R21)
PA-06-150 - Pilot and Feasibility Program in Hematologic Diseases (R21)
PA-06-152 - Calcium Oxalate Stone Diseases (R21)
PA-06-155 - Exploratory Grant Program in Diabetes Endocrinology and Metabolism (R21)
PA-06-156 - Pilot and Feasibility Program in Urology (R21)
PA-06-157 - Advances in Polycystic Kidney Disease (R21)
PA-06-162 - Basic and Clinical Studies of Congenital Urinary Tract Obstruction (R21)
PA-06-164 - Ancillary Studies of Kidney Disease Accessing Information from Clinical Trials, Epidemiological Studies, and Databases (R21)
PA-06-166 - Transmission of Human Immunodeficiency Virus (HIV) in Semen (R21)
PA-06-170 - Erythroid Lineage Molecular Toolbox (R21)
PA-06-174 - Diet Composition and Energy Balance (R21)
PA-06-178 -Research Grants For Studies Of Hepatitis C In The Setting Of Renal Disease (R21)
PA-06-183 - Health Disparities in NIDDK Diseases (R21)
PA-06-185 - Proteomics: Diabetes, Obesity, And Endocrine, Digestive, Kidney, Urologic, And Hematologic Diseases (R21)
PA-06-187- Heterogeneity of Fat Depots: Underlying Basis and Association with Morbidity (R21)
PA-06-228 - Exploratory Basic Research in Glomerular Disease (R21)
PA-06-229 - Intestinal Failure, Short Gut Syndrome and Small Bowel Transplantation (R21)
PA-06-232 - Developmental Biology and Regeneration of the Liver (R21
PA-06-255 - Basic Research in the Bladder and Lower Urinary Tract (R21)
PA-06-272 - Pancreatic Development and Regeneration: Toward Cellular Therapies for Diabetes (R21)

New or revised applications will NOT be accepted for the above reference PAs after November 15, 2006.

The NIDDK is participating in the NIH Exploratory/Developmental Research Grant Program (Parent R21) which may found at http://grants.nih.gov/grants/guide/pa-files/PA-06-181.html. Information about NIDDK’s R21 program can be found at http://www2.niddk.nih.gov/Funding/Grants/ApplicantGuidelines/R21.htm . Applicants with research interest in areas important to the NIDDK mission, who are considering applying to the Parent R21 announcement, are encouraged to consult with NIDDK Program Staff before submitting an application.

Inquiry

For questions regarding research areas important to the mission of NIDDK please contact:

For Diabetes, Endocrinology, and Metabolic Diseases:

Catherine McKeon, Ph.D.
6707 Democracy Boulevard, Room 6103
Bethesda, MD 20892-5460
Telephone: (301) 594-8810
FAX: (301) 480-3503
E-mail: mckeonc@extra.niddk.nih.gov

For Digestive Diseases, Obesity, and Nutrition:

Robert Karp, Ph.D.
6707 Democracy Boulevard, Room 671
Bethesda, MD 20892-5450
Telephone: (301)451-8875
FAX: (301) 480-8300
E-mail: KarpR@extra.niddk.nih.gov

For Kidney and Urologic Disorders:

Christian Ketchum, Ph.D.
6707 Democracy Boulevard, Room 647
Bethesda, MD 20892-5458
Telephone: (301) 594-7717
FAX: (301) 480-3510
E-mail: KetchumC@extra.niddk.nih.gov